Using Antibiotics Could Affect Checkpoint Inhibitors
February 14th 2017A recent study presented at the 2017 Genitourinary Cancers Symposium found that use of antibiotics could damper the efficacy of checkpoint inhibitors, potentially due to the relationship between gut microbiota and antibiotics.
Ribociclib Emerges as Option for Elderly Patients with HR+/HER2- Breast Cancer
February 7th 2017The clinical benefits and safety profiles for ribociclib remained consistent when treating both younger and elderly patients with hormone-receptor positive, human epidermal growth factor receptor-2 negative (HR+/HER2-) advanced breast cancer.